ISRAEL’S MEDICAL ACHIEVEMENTS
By Michael Ordman
Jerusalem displays Jewish-developed cholera vaccine
Dr. Waldemar Haffkine, a Russian-Jewish microbiologist, developed the cholera vaccine in 1892. Jerusalem’s Tower of David Museum is now exhibiting one of the original ampoules of vaccine. Dr. Haffkine also developed a vaccine for plague and was knighted by Queen Victoria in 1897. Sir Waldemar donated his extensive personal archive to the National Library of Israel.
ALS treatment trial shows success
Israel’s Brainstorm has announced positive final results from its phase 2a clinical trial of NurOwn cells in amyotrophic lateral sclerosis (ALS) patients used on 14 subjects at Hadassah Medical Center in Jerusalem. Nearly all subjects experienced clinical benefit.
Good results for Fabry Disease treatment
Israel’s Protalix Biotherepeutics reported good results in its trials of its PRX-102 treatment for the genetic disease Fabry’s. Even a low dosage had an average 78.8% decrease in the effect of pain on the patients’ functioning.
Teva launches a generic painkiller
Israel’s Teva has launched the first FDA-approved generic equivalent to Celebrex (Celecoxib) Capsules in the US. Celebrex is used to treat arthritis, pain, menstrual cramps, and colonic polyps.
The fruitful way to conceive
Israel’s Fruitful Way Ltd. has pioneered a new, natural fertility and conception toolkit for couples who are trying to get pregnant. It includes a unique, science-backed dietary supplement, scientifically mated with a sophisticated fertility app.
Israeli science saves 5-year-old girl
A 35-year-old study by Israel’s Professor Raphael Mechoulam convinced Denver-based physician Dr. Alan Shackelford to use synthesized cannabidiol or CBD to save 5-year-old Charlotte Figi who suffered 300 epileptic fits a week. Dr Shackelford immigrated to Israel in 2012.